$BFLY
Butterfly Network, Inc.

2021 Q2 Form 10-Q Financial Statement

#000155837021010985 Filed on August 09, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2 2020 Q1
Revenue $16.51M $11.79M $8.670M
YoY Change 40.04%
Cost Of Revenue $8.293M $11.63M $9.506M
YoY Change -28.67%
Gross Profit $8.220M $165.0K -$836.0K
YoY Change 4881.82%
Gross Profit Margin 49.78% 1.4% -9.64%
Selling, General & Admin $27.82M $11.30M $11.16M
YoY Change 146.27%
% of Gross Profit 338.43% 6846.06%
Research & Development $17.09M $11.94M $12.52M
YoY Change 43.12%
% of Gross Profit 207.88% 7236.36%
Depreciation & Amortization $455.0K $285.0K
YoY Change
% of Gross Profit 5.54%
Operating Expenses $44.91M $23.24M $23.67M
YoY Change 93.26%
Operating Profit -$36.69M -$23.07M -$24.51M
YoY Change 59.02%
Interest Expense $7.000K $113.0K $5.000K
YoY Change -93.81%
% of Operating Profit
Other Income/Expense, Net -$262.0K -$70.00K -$29.00K
YoY Change 274.29%
Pretax Income -$2.891M -$23.23M -$24.34M
YoY Change -87.56%
Income Tax $51.00K $10.00K $10.00K
% Of Pretax Income
Net Earnings -$2.942M -$23.24M -$24.35M
YoY Change -87.34%
Net Earnings / Revenue -17.82% -197.09% -280.9%
Basic Earnings Per Share -$0.02
Diluted Earnings Per Share -$0.02 -$1.227K $0.00
COMMON SHARES
Basic Shares Outstanding 192.2M 6.034M 5.979M
Diluted Shares Outstanding 192.2M

Balance Sheet

Concept 2021 Q2 2020 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $509.5M $900.0K $0.00
YoY Change 56510.56%
Cash & Equivalents $19.61M $73.43M $70.01M
Short-Term Investments $489.9M
Other Short-Term Assets $26.41M $300.0K
YoY Change 8703.0%
Inventory $46.95M
Prepaid Expenses
Receivables $7.809M
Other Receivables $0.00
Total Short-Term Assets $590.7M $1.250M $0.00
YoY Change 47168.46%
LONG-TERM ASSETS
Property, Plant & Equipment $7.436M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.883M $414.1M
YoY Change -99.55%
Other Assets $6.802M $300.0K
YoY Change
Total Long-Term Assets $40.60M $414.1M $300.0K
YoY Change -90.19%
TOTAL ASSETS
Total Short-Term Assets $590.7M $1.250M $0.00
Total Long-Term Assets $40.60M $414.1M $300.0K
Total Assets $631.3M $415.3M $300.0K
YoY Change 52.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.264M
YoY Change
Accrued Expenses $41.05M $67.67K $200.0K
YoY Change 60567.68%
Deferred Revenue $10.89M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $58.38M $14.60M $300.0K
YoY Change 299.83%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.282M
YoY Change
Total Long-Term Liabilities $2.282M $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $58.38M $14.60M $300.0K
Total Long-Term Liabilities $2.282M $0.00 $0.00
Total Liabilities $184.9M $14.56M $300.0K
YoY Change 1170.2%
SHAREHOLDERS EQUITY
Retained Earnings -$398.4M -$64.10K
YoY Change 621497.84%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $446.4M -$254.3M -$233.8M
YoY Change
Total Liabilities & Shareholders Equity $631.3M $415.3M $300.0K
YoY Change 52.0%

Cashflow Statement

Concept 2021 Q2 2020 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income -$2.942M -$23.24M -$24.35M
YoY Change -87.34%
Depreciation, Depletion And Amortization $455.0K $285.0K
YoY Change
Cash From Operating Activities -$36.50M -$390.0K -$19.67M
YoY Change 9258.72%
INVESTING ACTIVITIES
Capital Expenditures -$539.0K $480.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $36.40M -$414.0M
YoY Change -108.79%
Cash From Investing Activities $35.86M -$414.0M -$480.0K
YoY Change -108.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.401M 415.3M 154.0K
YoY Change -98.7%
NET CHANGE
Cash From Operating Activities -36.50M -390.0K -19.67M
Cash From Investing Activities 35.86M -414.0M -480.0K
Cash From Financing Activities 5.401M 415.3M 154.0K
Net Change In Cash 4.759M 910.0K -20.00M
YoY Change 422.97%
FREE CASH FLOW
Cash From Operating Activities -$36.50M -$390.0K -$19.67M
Capital Expenditures -$539.0K $480.0K
Free Cash Flow -$35.96M -$20.15M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001804176
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2020Q2 bfly Value Of Public Warrants Issued Per Unit Issued During Ipo
ValueOfPublicWarrantsIssuedPerUnitIssuedDuringIpo
0.33
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39292
dei Entity Registrant Name
EntityRegistrantName
Butterfly Network, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-4618156
dei Entity Address Address Line1
EntityAddressAddressLine1
530 Old Whitfield Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Guilford
dei Entity Address State Or Province
EntityAddressStateOrProvince
CT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
06437
dei City Area Code
CityAreaCode
203
dei Local Phone Number
LocalPhoneNumber
689-5650
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19605000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60206000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2998000
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9294000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
590660000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
97332000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7436000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6870000
CY2021Q2 bfly Vendor Advances Non Current
VendorAdvancesNonCurrent
26365000
CY2020Q4 bfly Vendor Advances Non Current
VendorAdvancesNonCurrent
37390000
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6802000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5599000
CY2021Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
489890000
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7809000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5752000
CY2021Q2 us-gaap Inventory Net
InventoryNet
46947000
CY2020Q4 us-gaap Inventory Net
InventoryNet
25805000
CY2021Q2 bfly Vendor Advances Current
VendorAdvancesCurrent
17115000
CY2020Q4 bfly Vendor Advances Current
VendorAdvancesCurrent
2571000
CY2021Q2 us-gaap Assets
Assets
631263000
CY2020Q4 us-gaap Assets
Assets
147191000
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5264000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
16400000
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
10894000
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
8293000
us-gaap Gross Profit
GrossProfit
14638000
us-gaap Gross Profit
GrossProfit
-671000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17088000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11940000
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
11627000
us-gaap Cost Of Revenue
CostOfRevenue
14320000
us-gaap Cost Of Revenue
CostOfRevenue
21133000
CY2021Q2 us-gaap Gross Profit
GrossProfit
8220000
CY2020Q2 us-gaap Gross Profit
GrossProfit
165000
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5341000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
51920000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8443000
CY2021Q2 bfly Accrued Purchase Commitments Current
AccruedPurchaseCommitmentsCurrent
22890000
CY2020Q4 bfly Accrued Purchase Commitments Current
AccruedPurchaseCommitmentsCurrent
22890000
CY2021Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
19327000
CY2020Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
21962000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
58375000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
69695000
CY2021Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
4840000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2790000
CY2020Q4 us-gaap Convertible Debt
ConvertibleDebt
49528000
CY2020Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
4366000
CY2021Q2 bfly Warrant Liability
WarrantLiability
99754000
CY2021Q2 bfly Accrued Purchase Commitments Non Current
AccruedPurchaseCommitmentsNonCurrent
19660000
CY2020Q4 bfly Accrued Purchase Commitments Non Current
AccruedPurchaseCommitmentsNonCurrent
19660000
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2282000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2146000
CY2021Q2 us-gaap Liabilities
Liabilities
184911000
CY2020Q4 us-gaap Liabilities
Liabilities
148185000
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
360937000
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
844770000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
32874000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-398438000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-394806000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
446352000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-361931000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
631263000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
147191000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16513000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11792000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
28958000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20462000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32804000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24456000
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10540000
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5955000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
20347000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11870000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17279000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10583000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
44907000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
23236000
us-gaap Operating Expenses
OperatingExpenses
105071000
us-gaap Operating Expenses
OperatingExpenses
46909000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-36687000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-23071000
us-gaap Operating Income Loss
OperatingIncomeLoss
-90433000
us-gaap Operating Income Loss
OperatingIncomeLoss
-47580000
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
607000
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
23000
us-gaap Investment Income Interest
InvestmentIncomeInterest
846000
us-gaap Investment Income Interest
InvestmentIncomeInterest
222000
CY2021Q2 us-gaap Interest Expense
InterestExpense
7000
CY2020Q2 us-gaap Interest Expense
InterestExpense
113000
us-gaap Interest Expense
InterestExpense
645000
us-gaap Interest Expense
InterestExpense
118000
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-33458000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-87570000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-262000
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-70000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-895000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-99000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2891000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23231000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3557000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-47575000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
51000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
75000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2942000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-23241000
us-gaap Net Income Loss
NetIncomeLoss
-3632000
us-gaap Net Income Loss
NetIncomeLoss
-47595000
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.85
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-7.92
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
192180141
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6034191
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
149286700
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6006711
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-233781000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-23241000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
70000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2690000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-254262000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-212278000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1908000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4501000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2928000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
986000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-44000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-492343000
us-gaap Net Income Loss
NetIncomeLoss
-47595000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
224000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5387000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-254262000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
436163000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2942000
CY2021Q2 bfly Stock Issued During Period Value Stock Options And Warrants Exercised
StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised
5376000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7755000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
446352000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-361931000
us-gaap Net Income Loss
NetIncomeLoss
-3632000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11689000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
360937000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
49917000
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
361287000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
28085000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
446352000
us-gaap Profit Loss
ProfitLoss
-3632000
us-gaap Profit Loss
ProfitLoss
-47595000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
915000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
593000
us-gaap Paid In Kind Interest
PaidInKindInterest
389000
us-gaap Paid In Kind Interest
PaidInKindInterest
113000
us-gaap Share Based Compensation
ShareBasedCompensation
28035000
us-gaap Share Based Compensation
ShareBasedCompensation
5345000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-87570000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
498000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1000000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1979000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3198000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
21113000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2994000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6352000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-535000
bfly Increase Decrease In Vendor Advances
IncreaseDecreaseInVendorAdvances
3519000
bfly Increase Decrease In Vendor Advances
IncreaseDecreaseInVendorAdvances
-2281000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-11088000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1630000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-99929000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39406000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
692514000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
202000000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1829000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1908000
bfly Proceeds From Exercise Of Stock Options And Warrants
ProceedsFromExerciseOfStockOptionsAndWarrants
11686000
bfly Proceeds From Exercise Of Stock Options And Warrants
ProceedsFromExerciseOfStockOptionsAndWarrants
224000
bfly Proceeds From Equity Infusion From Business Combination Net
ProceedsFromEquityInfusionFromBusinessCombinationNet
548403000
bfly Proceeds From Equity Infusion From Business Combination Net
ProceedsFromEquityInfusionFromBusinessCombinationNet
0
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
4366000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
20150000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
4366000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
52000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
555671000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24740000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-36601000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16574000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60206000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
90002000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23605000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
73428000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19605000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
73428000
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
4000000
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23605000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
73428000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 10pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents, marketable securities and accounts receivable. At June 30, 2021, substantially all of the Company’s marketable securities were invested in mutual funds with one financial institution. At December 31, 2020, substantially all of the Company’s cash and cash equivalents were invested in money market accounts at one financial institution. The Company also maintains balances in various operating accounts above federally insured limits. The Company has not experienced significant losses on such accounts and does not believe it is exposed to any significant credit risk on cash and cash equivalents and marketable securities.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">As of June 30, 2021 and December 31, 2020, no customer accounts for more than 10% of the Company’s accounts receivable. For the three and six months ended June 30, 2021 and 2020, no customer accounts for more than 10% of the total revenues.</p>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 10pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The Company makes estimates and assumptions about future events that affect the amounts reported in its condensed consolidated financial statements and accompanying notes. Future events and their effects cannot be determined with certainty. On an ongoing basis, management evaluates these estimates, judgments and assumptions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 10pt 0pt;">The Company bases its estimates on historical and anticipated results and trends and on various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates, and any such differences may be material to the Company’s condensed consolidated financial statements. Except with respect to estimates related to the warrant liabilities, there have been no material changes to the Company’s use of estimates as described in the audited consolidated financial statements as of December 31, 2020.</p>
CY2021Q2 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-200000
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-500000
CY2021Q1 bfly Merger Agreement Right To Receive Shares At Effective Time Upon Conversion
MergerAgreementRightToReceiveSharesAtEffectiveTimeUponConversion
1.0383
CY2021Q1 bfly Business Combination Increase In Cash
BusinessCombinationIncreaseInCash
589500000
CY2021Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
11400000
CY2021Q1 us-gaap Business Combination Consideration Transferred Liabilities Incurred
BusinessCombinationConsiderationTransferredLiabilitiesIncurred
30900000
CY2021Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
186500000
CY2021Q1 bfly Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Warrant Liability
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiability
187300000
CY2021Q1 bfly Business Combination Additional Proceeds
BusinessCombinationAdditionalProceeds
600000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16513000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11792000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
28958000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20462000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16513000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11792000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
28958000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20462000
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7809000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5752000
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
10894000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8443000
CY2021Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
4840000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2790000
bfly Duration For Payment Terms
DurationForPaymentTerms
P30D
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
400000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
600000
CY2021Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3600000
CY2020Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
900000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
5600000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1900000
CY2021Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
20600000
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.64
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.36
CY2020Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1524000
CY2020Q4 bfly Number Of Series Of Convertible Preferred Stock
NumberOfSeriesOfConvertiblePreferredStock
4
CY2020Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
107197118
CY2021Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
32020000
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
7688000
CY2021Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
776000
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
865000
CY2021Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
14151000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
17252000
CY2021Q2 us-gaap Inventory Net
InventoryNet
46947000
CY2020Q4 us-gaap Inventory Net
InventoryNet
25805000
CY2020Q2 us-gaap Inventory Write Down
InventoryWriteDown
700000
us-gaap Inventory Write Down
InventoryWriteDown
700000
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11754000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10268000
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4318000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3398000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7436000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6870000
CY2021Q2 us-gaap Security Deposit
SecurityDeposit
1883000
CY2020Q4 us-gaap Security Deposit
SecurityDeposit
1888000
CY2021Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
4000000
CY2020Q4 us-gaap Deferred Costs
DeferredCosts
3711000
CY2021Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
919000
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6802000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5599000
CY2021Q2 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
167000
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8177000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5968000
CY2021Q2 us-gaap Deposit Liability Current
DepositLiabilityCurrent
1165000
CY2020Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
1177000
CY2021Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
370000
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
646000
CY2021Q2 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
3560000
CY2020Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
3695000
CY2021Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3293000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5432000
CY2020Q4 bfly Vendor Settlements
VendorSettlements
2975000
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2762000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2069000
CY2021Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
19327000
CY2020Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
21962000
CY2021Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1186000
CY2020Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1099000
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1826000
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
876000
CY2020Q2 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
788000
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-225000
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
1512000
CY2021Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
192000
CY2020Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
363000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
440000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
864000
CY2021Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1161000
CY2020Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1524000
CY2021Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1161000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1000000.0
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7738000
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2662000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
28035000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5345000
CY2021Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
2942000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2942000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
192180141
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
192180141
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2020Q2 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
23241000
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-23241000
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6034191
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6034191
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.85
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
3632000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3632000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
149286700
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
149286700
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
47595000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-47595000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6006711
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6006711
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-7.92
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
41343105
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
133935332
CY2020 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
50000000.0
CY2020 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
49900000
us-gaap Interest Expense Debt
InterestExpenseDebt
600000
us-gaap Interest Expense Debt
InterestExpenseDebt
100000
CY2021Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
0.0
CY2020Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
100000
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-33500000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-87600000
CY2021Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
600000
CY2020Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
500000
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1100000
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
597000
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
2453000
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
3832000
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
4528000
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
4672000
CY2021Q2 bfly Operating Lease Future Minimum Payments Due Year Four And After Year Four
OperatingLeaseFutureMinimumPaymentsDueYearFourAndAfterYearFour
27081000
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
43163000

Files In Submission

Name View Source Status
0001558370-21-010985-index-headers.html Edgar Link pending
0001558370-21-010985-index.html Edgar Link pending
0001558370-21-010985.txt Edgar Link pending
0001558370-21-010985-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmb-20210630.xsd Edgar Link pending
tmb-20210630x10q.htm Edgar Link pending
tmb-20210630x10q006.jpg Edgar Link pending
tmb-20210630x10q007.jpg Edgar Link pending
tmb-20210630x10q_htm.xml Edgar Link completed
tmb-20210630xex10d2.htm Edgar Link pending
tmb-20210630xex10d2001.jpg Edgar Link pending
tmb-20210630xex10d3.htm Edgar Link pending
tmb-20210630xex10d3001.jpg Edgar Link pending
tmb-20210630xex10d5.htm Edgar Link pending
tmb-20210630xex10d5001.jpg Edgar Link pending
tmb-20210630xex31d1.htm Edgar Link pending
tmb-20210630xex31d2.htm Edgar Link pending
tmb-20210630xex32.htm Edgar Link pending
tmb-20210630_cal.xml Edgar Link unprocessable
tmb-20210630_def.xml Edgar Link unprocessable
tmb-20210630_lab.xml Edgar Link unprocessable
tmb-20210630_pre.xml Edgar Link unprocessable